![Jonathan P. Jones](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Jonathan P. Jones first degree
Entity | Entity type | Industry | |
---|---|---|---|
Phase4 Partners Ltd.
![]() Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK.
8
| Private Company | Investment Managers | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jonathan P. Jones via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AVAX TECHNOLOGIES, INC. | Biotechnology | Corporate Officer/Principal | |
PRA HEALTH SCIENCES, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Nomura International Plc
![]() Nomura International Plc Investment Banks/BrokersFinance Nomura International Plc provides a variety of financial services including advisement, investment banking and asset management. It trades in and sells fixed income and equity products, including related derivatives; and provides investment banking services, and corporate finance and private equity services. The company is also involved in asset and principal finance business. It offers investment advisory and management, custody, and employment services. Nomura International was founded in 1981 and is headquartered in London, the United Kingdom. | Investment Banks/Brokers | Corporate Officer/Principal | |
Renovis, Inc.
![]() Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Director/Board Member | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Gilead Colorado, Inc.
![]() Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | President | |
ZP Opco, Inc.
![]() ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member | |
ABBVIE INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Oxford | College/University | Graduate Degree | |
Rockhurst University | College/University | Masters Business Admin | |
University of Missouri | College/University | Doctorate Degree | |
Benedictine College | College/University | Undergraduate Degree | |
British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member | |
University of British Columbia | College/University | Graduate Degree Doctorate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree | |
University Of Dundee | College/University | Doctorate Degree | |
University of Birmingham | College/University | Doctorate Degree | |
Chroma Therapeutics Ltd.
![]() Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Heriot-Watt University | College/University | Doctorate Degree | |
Nabriva Therapeutics GmbH
![]() Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman | |
King's College London | College/University | Doctorate Degree | |
Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | ||
Albireo Ltd.
![]() Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Albireo AB
![]() Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Elastagen Pty Ltd.
![]() Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Medical Specialties | Director of Finance/CFO | |
The Royal College of Surgeons of Edinburgh | College/University | Corporate Officer/Principal | |
OneVentures Management Pty Ltd.
![]() OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures Management Pty Ltd. (OneVentures) is a venture capital firm, a susbidiary of Andover Group Pty Ltd was founded in 2006 by Dr Michelle Deaker. The firm is headquartered in Australia. | Investment Managers | Private Equity Investor | |
CRISPR THERAPEUTICS AG | Biotechnology | Founder | |
MEREO BIOPHARMA GROUP PLC | Biotechnology | Founder Founder | |
ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
ERS Genomics Ltd.
![]() ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Biotechnology | Founder | |
Mereo Biopharma 3 Ltd.
![]() Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Part of Mereo BioPharma Group Plc, Mereo Biopharma 3 Ltd. develops bio pharm products. The company is based in London, UK. | Biotechnology | Director/Board Member Director/Board Member | |
Mereo BioPharma 2 Ltd.
![]() Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 2 Ltd. is a British company that provides research and experimental development for biotechnology. The company is based in London, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ELANCO ANIMAL HEALTH INCORPORATED | Biotechnology | Director/Board Member | |
Mereo BioPharma 4 Ltd.
![]() Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 4 Ltd. is a British biotechnology company founded in 2017 that provides research and development services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Amplitude Ventures
![]() Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada. | Investment Managers | Consultant / Advisor | |
Xap Therapeutics Ltd
![]() Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Xap Therapeutics Ltd is a British company that specializes in developing tailor-made therapies for the treatment of complex diseases such as cancer and autoimmunity. Xap Therapeutics is based in Cambridge, UK and was founded in 2017 by Shaun Patrick Foy and James Patterson. The company takes inspiration from the principle of exaptation and uses the power of genome editing and synthetic biology to convert nature's ultimate first-responder cell into a modular chassis, ready to be programmed to treat disease. The company's interdisciplinary team of exceptional scientists is key to its success. | Pharmaceuticals: Major | Founder |
Statistics
International
United States | 24 |
United Kingdom | 17 |
Canada | 4 |
Australia | 3 |
Austria | 2 |
Sectoral
Health Technology | 30 |
Consumer Services | 12 |
Commercial Services | 6 |
Finance | 4 |
Miscellaneous | 2 |
Operational
Director/Board Member | 38 |
Corporate Officer/Principal | 12 |
Private Equity Investor | 7 |
Founder | 6 |
Undergraduate Degree | 6 |
Most connected contacts
- Stock Market
- Insiders
- Jonathan P. Jones
- Company connections